Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Immunomodulary Effects of Arginine Supplementation in Colitis and Colon Cancer

NCT01091558 is registered in ClinicalTrials.gov with Vanderbilt University Medical Center as lead sponsor.

NCT NCT01091558
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01091558 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Immunomodulary Effects of Arginine Supplementation in Colitis and Colon Cancer
Lead sponsor
Vanderbilt University Medical Center
Phase
Observational
Overall status
Completed
Start date
September 30, 2009
Completion date
December 31, 2011
Enrollment
204 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

colon cancer, ulcerative colitis